En el mes de la concesión de los Premios Nobel, rendimos homenaje a Alfred Nobel y a los galardonados con el Premio de Fisiología y Medicina de 2018

Autores/as

  • Francisco J. Sánchez-Muniz Catedrático de Nutrición. Facultad de Farmacia de la Universidad Complutense de Madrid y Académico de número de la Real Academia Nacional de Farmacia
  • Jesús M. Culebras De la Real Academia de Medicina y Cirugía de Valladolid y del IBIOMED, Universidad de León. Director de Journal of Negative & No Positive Results
  • Luis Vicente-Vacas Editor de Journal of Negative & No Positive Results

DOI:

https://doi.org/10.19230/jonnpr.2777

Palabras clave:

-

Resumen

-

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Sánchez-Muniz FJ, Culebras JM, Vacas LV. In the month of the Nobel Prize Awards, we pay tribute to Alfred Nobel and to the recipients of the 2017 Prize in Physiology and Medicine. JONNPR 2017; 2(11): 577-580.

Rincón del vago https://www.rincondelvago.com/informacion/premios- nobel/

https://www.google.es/search?newwindow=1&client=firefoxb&dcr=0&tbm=isch&sa=1&q=Fotos+de+Alfred+Nobel+&oq

Sánchez-Muniz FJ, Simón Martín C. Clock genes, chronodisruption, nutrition and obesity. Current Research in Diabetes & Obesity Journal 2017; 3(2)CRDJ. MS.ID. 555607.

Simón Martin C, Sánchez-Muniz FJ. Cronodisrupción y desequilibrio entre cortisol y melatonina ¿Una antesala probable de las patologías crónicas degenerativas más prevalentes? JONNPR, 2017; 2(11): 619-633.

Premio Nobel de Medicina 2011: Página Oficial. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/

Geffner J, Rabinovich GA. [Nobel Prizes 2011: dendritic cells, toll-like receptors and their contribution to fundamental and translational medicine]. Rev Fac Cien Med Univ Nac Cordoba.

NobelPrize.org. Nobel Media AB 2018. Wed. 3 Oct 2018. https://www.nobelprize.org/prizes/medicine/2018/press-release/

Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996; 271(5256): 1734–1736.

Kwon E D, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sci USA. 1997; 94(15): 8099–8103.

Liu D, Jenkins RW, Sullivan RJ. Mechanisms of resistance to immune checkpoint blockade. Am J Clin Dermatol. 2018. Sep 26. doi: 10.1007/s40257-018-0389-y.

Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A, Padera R, Jaklitsch MT, Shanka S, Chen TC, Korman A, Allison JP, Dranoff G. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA. 2003; 100(8): 4712-4717.

Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11(11): 3887–3895.

Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of Lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151.

Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H. Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000; 192(7): 1027–1034.

Iwai Y, Terawaki S, Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol. 2005; 17(2): 133–144.

Publicado

2018-10-10